These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

835 related articles for article (PubMed ID: 29754392)

  • 1. FTO, m
    Mauer J; Jaffrey SR
    FEBS Lett; 2018 Jun; 592(12):2012-2022. PubMed ID: 29754392
    [TBL] [Abstract][Full Text] [Related]  

  • 2. METTL3 and ALKBH5 oppositely regulate m
    Song H; Feng X; Zhang H; Luo Y; Huang J; Lin M; Jin J; Ding X; Wu S; Huang H; Yu T; Zhang M; Hong H; Yao S; Zhao Y; Zhang Z
    Autophagy; 2019 Aug; 15(8):1419-1437. PubMed ID: 30870073
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oncogenic and Tumor-Suppressive Functions of the RNA Demethylase FTO.
    Zuidhof HR; Calkhoven CF
    Cancer Res; 2022 Jun; 82(12):2201-2212. PubMed ID: 35303057
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The dynamic epitranscriptome: N6-methyladenosine and gene expression control.
    Meyer KD; Jaffrey SR
    Nat Rev Mol Cell Biol; 2014 May; 15(5):313-26. PubMed ID: 24713629
    [TBL] [Abstract][Full Text] [Related]  

  • 5. m
    Nagaki Y; Motoyama S; Yamaguchi T; Hoshizaki M; Sato Y; Sato T; Koizumi Y; Wakita A; Kawakita Y; Imai K; Nanjo H; Watanabe H; Imai Y; Minamiya Y; Kuba K
    Genes Cells; 2020 Aug; 25(8):547-561. PubMed ID: 32449584
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of Flavin Mononucleotide as a Cell-Active Artificial N
    Xie LJ; Yang XT; Wang RL; Cheng HP; Li ZY; Liu L; Mao L; Wang M; Cheng L
    Angew Chem Int Ed Engl; 2019 Apr; 58(15):5028-5032. PubMed ID: 30756480
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The comprehensive interactomes of human adenosine RNA methyltransferases and demethylases reveal distinct functional and regulatory features.
    Covelo-Molares H; Obrdlik A; Poštulková I; Dohnálková M; Gregorová P; Ganji R; Potěšil D; Gawriyski L; Varjosalo M; Vaňáčová Š
    Nucleic Acids Res; 2021 Nov; 49(19):10895-10910. PubMed ID: 34634806
    [TBL] [Abstract][Full Text] [Related]  

  • 8. FTO-Dependent
    Huang H; Wang Y; Kandpal M; Zhao G; Cardenas H; Ji Y; Chaparala A; Tanner EJ; Chen J; Davuluri RV; Matei D
    Cancer Res; 2020 Aug; 80(16):3200-3214. PubMed ID: 32606006
    [No Abstract]   [Full Text] [Related]  

  • 9. The dual role of N6-methyladenosine modification of RNAs is involved in human cancers.
    He L; Li J; Wang X; Ying Y; Xie H; Yan H; Zheng X; Xie L
    J Cell Mol Med; 2018 Oct; 22(10):4630-4639. PubMed ID: 30039919
    [TBL] [Abstract][Full Text] [Related]  

  • 10. N(6)-Methyladenosine: a conformational marker that regulates the substrate specificity of human demethylases FTO and ALKBH5.
    Zou S; Toh JD; Wong KH; Gao YG; Hong W; Woon EC
    Sci Rep; 2016 May; 6():25677. PubMed ID: 27156733
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structural insights into FTO's catalytic mechanism for the demethylation of multiple RNA substrates.
    Zhang X; Wei LH; Wang Y; Xiao Y; Liu J; Zhang W; Yan N; Amu G; Tang X; Zhang L; Jia G
    Proc Natl Acad Sci U S A; 2019 Feb; 116(8):2919-2924. PubMed ID: 30718435
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Distinct RNA
    Toh JDW; Crossley SWM; Bruemmer KJ; Ge EJ; He D; Iovan DA; Chang CJ
    Proc Natl Acad Sci U S A; 2020 Oct; 117(41):25284-25292. PubMed ID: 32989163
    [TBL] [Abstract][Full Text] [Related]  

  • 13. FTO: An Emerging Molecular Player in Neuropsychiatric Diseases.
    Annapoorna PK; Iyer H; Parnaik T; Narasimhan H; Bhattacharya A; Kumar A
    Neuroscience; 2019 Oct; 418():15-24. PubMed ID: 31442565
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NADP modulates RNA m
    Wang L; Song C; Wang N; Li S; Liu Q; Sun Z; Wang K; Yu SC; Yang Q
    Nat Chem Biol; 2020 Dec; 16(12):1394-1402. PubMed ID: 32719557
    [TBL] [Abstract][Full Text] [Related]  

  • 15. m
    Takemoto S; Nakano M; Fukami T; Nakajima M
    Biochem Pharmacol; 2021 Nov; 193():114766. PubMed ID: 34536357
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Demethylases in tumors and the tumor microenvironment: Key modifiers of N
    Guo J; Zhao L; Duan M; Yang Z; Zhao H; Liu B; Wang Y; Deng L; Wang C; Jiang X; Jiang X
    Biomed Pharmacother; 2024 May; 174():116479. PubMed ID: 38537580
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel Prognostic Implications of Methylated RNA and Demethylases in Resected HCC and Background Liver Tissue.
    Nakagawa N; Tanaka K; Sonohara F; Kandimalla R; Sunagawa Y; Inokawa Y; Takami H; Hayashi M; Yamada S; Kanda M; Tanaka C; Nakayama G; Koike M; Kodera Y
    Anticancer Res; 2020 Dec; 40(12):6665-6676. PubMed ID: 33288560
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of formaldehyde dehydrogenase-coupled assay and antibody-based assays for ALKBH5 activity evaluation.
    Shen DD; Suo FZ; Song QM; Chang J; Zhang T; Hong JJ; Zheng YC; Liu HM
    J Pharm Biomed Anal; 2019 Jan; 162():9-15. PubMed ID: 30219599
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dynamic RNA modifications in disease.
    Klungland A; Dahl JA
    Curr Opin Genet Dev; 2014 Jun; 26():47-52. PubMed ID: 25005745
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased N6-methyladenosine causes infertility is associated with FTO expression.
    Ding C; Zou Q; Ding J; Ling M; Wang W; Li H; Huang B
    J Cell Physiol; 2018 Sep; 233(9):7055-7066. PubMed ID: 29384212
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 42.